Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 1
2016 3
2017 4
2018 5
2019 2
2020 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
MUC1 Aptamer Targeted SERS Nanoprobes.
Pal S, Harmsen S, Oseledchyk A, Hsu HT, Kircher MF. Pal S, et al. Among authors: oseledchyk a. Adv Funct Mater. 2017 Aug 25;27(32):1606632. doi: 10.1002/adfm.201606632. Epub 2017 Jul 6. Adv Funct Mater. 2017. PMID: 29147108 Free PMC article.
Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus.
Oseledchyk A, Ricca JM, Gigoux M, Ko B, Redelman-Sidi G, Walther T, Liu C, Iyer G, Merghoub T, Wolchok JD, Zamarin D. Oseledchyk A, et al. Oncotarget. 2018 Jun 19;9(47):28702-28716. doi: 10.18632/oncotarget.25614. eCollection 2018 Jun 19. Oncotarget. 2018. PMID: 29983890 Free PMC article.
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy.
Zamarin D, Ricca JM, Sadekova S, Oseledchyk A, Yu Y, Blumenschein WM, Wong J, Gigoux M, Merghoub T, Wolchok JD. Zamarin D, et al. Among authors: oseledchyk a. J Clin Invest. 2018 Apr 2;128(4):1413-1428. doi: 10.1172/JCI98047. Epub 2018 Mar 5. J Clin Invest. 2018. PMID: 29504948 Free PMC article.
Surgical ovarian suppression for adjuvant treatment in hormone receptor positive breast cancer in premenopausal patients.
Oseledchyk A, Gemignani ML, Zhou QC, Iasonos A, Elahjji R, Adamou Z, Feit N, Goldfarb SB, Long Roche K, Sonoda Y, Goldfrank DJ, Chi DS, Saban SS, Broach V, Abu-Rustum NR, Carter J, Leitao M, Zivanovic O. Oseledchyk A, et al. Int J Gynecol Cancer. 2021 Feb;31(2):222-231. doi: 10.1136/ijgc-2020-001966. Epub 2020 Dec 3. Int J Gynecol Cancer. 2021. PMID: 33273020 Free PMC article.
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy.
Zamarin D, Ricca JM, Sadekova S, Oseledchyk A, Yu Y, Blumenschein WM, Wong J, Gigoux M, Merghoub T, Wolchok JD. Zamarin D, et al. Among authors: oseledchyk a. J Clin Invest. 2018 Nov 1;128(11):5184. doi: 10.1172/JCI125039. Epub 2018 Oct 2. J Clin Invest. 2018. PMID: 30277478 Free PMC article. No abstract available.
Imaging of Liver Tumors Using Surface-Enhanced Raman Scattering Nanoparticles.
Andreou C, Neuschmelting V, Tschaharganeh DF, Huang CH, Oseledchyk A, Iacono P, Karabeber H, Colen RR, Mannelli L, Lowe SW, Kircher MF. Andreou C, et al. Among authors: oseledchyk a. ACS Nano. 2016 May 24;10(5):5015-26. doi: 10.1021/acsnano.5b07200. Epub 2016 May 10. ACS Nano. 2016. PMID: 27078225 Free PMC article.
18 results